We found that the loss of LPCAT1 resulted in the downregulation of SQLE and MSMO1 and upregulation of INSIG-1 in vitro (Fig. 5B), suggesting that the cholesterol metabolism pathway is involved in the inhibition of ESCC development. This evidence concerns the gene INSIG1 and esophageal squamous cell carcinoma.